Two-photon endoscopic scanning assembly for inflammatory disease detection
View Patent ↗An endscopic imaging device is described that achieves longitudinal axis (z-axis) scanning into a tissue or sample, using a piezoelectric microactuator. In some configurations, additional lateral (xy-plane) scanning is also achieved, to allow for the creation of full three-dimensional imaging, ex vivo or in vivo. The techniques may be used to image and diagnosis allergic rhinitis and eosinophilic esophagitis in tissue.
1. A method of detecting a biomarker within a 3-dimensional volume of a sample, the method comprising:
providing an endoscopic assembly for producing an output laser energy, the endoscopic assembly comprising an xy scanning stage and an actuator stage for z-axis scanning within the sample;
the xy scanning stage scanning the output laser beam over a planar scan area of the sample;
the actuator stage scanning the output laser beam over a depth range of the sample, where the depth range and the planar scan area form the 3-dimensional volume, driving the actuator stage using a piezoelectric stage, and mechanically amplifying a resulting displacement of the piezoelectric stage to scan the two-photon output beam over the entire depth range;
sampling a plurality of points within the sample by collecting fluorescence resulting from interaction of the output laser beam and the sample at each of the points; and
detecting the biomarker from the fluorescence collected from each the plurality of points.
2. The method of claim 1 , wherein the sample is biological tissue and the biomarker indicates an inflammation condition within the biological tissue.
3. The method of claim 2 , wherein the inflammation condition is eosinophilic esophagitis disease.
4. The method of claim 2 , wherein the inflammation condition is allergic rhinitis.
5. The method of claim 1 , wherein the depth range extends below an upper surface of the tissue between 0 and 500 μm along the z-axis.
6. The method of claim 1 , further comprising scanning the actuator stage at a scanning frequency of 0 to 500 Hz.
7. The method of claim 1 , wherein detecting the biomarker comprises comparing fluorescence collected at a first subset of the plurality of points against fluorescence collected at a second subset of the plurality of points.
8. The method of claim 1 , wherein detecting the biomarker comprises comparing fluorescence collected at the plurality of points against historical fluorescence data collected from the sample.